BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Rosuvastatin Calcium

A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.

216+ PubMed studies analyzed · 26 RCTs · Evidence Score: 50.4

Research Domains

Rosuvastatin Calcium has been studied across 13 research domains including 🦴 Bone & Joint, 🔥 Metabolic, ❤️ Cardiovascular, 🫁 Liver & Detox, 🔬 Oncology. The primary research focus is 🦴 Bone & Joint with 56% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Rosuvastatin Calcium, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Pravastatin
2 shared targets
Artemether
2 shared targets
Ezetimibe
2 shared targets
Calcitriol
2 shared targets
Testosterone
2 shared targets
Adenosine
2 shared targets
Flutamide
2 shared targets
Simvastatin
2 shared targets
Dactinomycin
2 shared targets
Lovastatin
2 shared targets
Loading evidence profile...

This evidence profile for Rosuvastatin Calcium is generated deterministically from 216 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.